Study Stopped
Study staff were busy with other projects and unable to devote time to this study
Preoperative Inspiratory Muscle Training
Telehealth-Delivered Preoperative Inspiratory Muscle Training: An Innovative Solution to Conserve Scarce ICU Resources
2 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
In light of the corona virus pandemic (COVID-19), there is critical need to conserve scarce mechanical ventilation (MV) resources. This study evaluates an intervention in non-infected cardiac patients as a means to assist with minimizing MV and ICU length of stay (LOS). Pre-op inspiratory muscle training (IMT) has been shown to decrease pulmonary complications, MV dependence, and ICU LOS following thoracic surgery. The investigators aim to determine the mechanism of remodeling in diaphragms of adults who undergo pre-op IMT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2022
CompletedJanuary 21, 2022
January 1, 2022
1 month
June 2, 2020
January 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Maximal inspiratory pressure
Maximal inspiratory pressure will be quantified in cm of water pressure.
Post breathing exercise sessions (up to 4 weeks)
Muscle fiber cross-sectional area and fiber type proportion.
Histology will be used to determine fiber type and cross-sectional area using primary antibodies for laminin and type-specific myosin heavy chain, followed by a triple immunofluorescence-conjugated secondary antibody labeling technique.
Intra-operatively
Secondary Outcomes (8)
Peak expiratory flow
Post breathing exercise sessions (up to 4 weeks)
Time to extubation
Up to discharge from ICU
Length of ICU stay
Up to 1 month
Length of hospital stay
Up to 1 month
Neuromuscular junction morphology
Intra-operatively
- +3 more secondary outcomes
Study Arms (2)
Inspiratory Muscle Training (IMT)
EXPERIMENTALPre-operative inspiratory muscle training
Relaxation Breathing (RLX)
EXPERIMENTALRelaxation breathing exercises
Interventions
Inspiratory muscle training exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.
Relaxation breathing exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.
Eligibility Criteria
You may qualify if:
- Cardiac surgery candidate
- Ability to complete pre-operative breathing exercises
You may not qualify if:
- Surgery is scheduled in less than 2 weeks
- New York Heart Association Class III or IV Cardiac Disease
- History of hemiparesis
- History of spinal cord injury
- History of progressive neuromuscular disease that may interfere with the ability to complete study interventions
- Previous cardiothoracic surgery within the last 12 weeks
- History of pneumonectomy
- History of lung surgery
- History of skeletal pathology (e.g. scoliosis) that may interfere with chest wall movements
- Routine usage of muscle relaxants, immunosuppressants, or corticosteroid medications within the past 30 days
- Forced expiratory volume 1 less than 40% of age-predicted value
- Presence of active malignancy
- Presence of any organ dysfunction that may limit ability to participate in seated respiratory exercises
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Smith, PhD, PT
University of Florida
- PRINCIPAL INVESTIGATOR
Thomas Beaver, MD, MPH
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 9, 2020
Study Start
December 1, 2021
Primary Completion
January 5, 2022
Study Completion
January 5, 2022
Last Updated
January 21, 2022
Record last verified: 2022-01